22 insiders reported 426 Form 4 transactions for BeOne Medicines Ltd. (ONC) over the past 18 months (most recent 2026-09-16). Recent activity: BAKER FELIX (Director) Buy 30,768 shares, BAKER BROS. ADVISORS LP (Director) Buy 30,768 shares, BAKER BROS. ADVISORS LP (Director) Buy 30,768 shares, Baker Brothers Life Sciences LP (Director) Buy 30,768 shares, 667, L.P. (Director) Buy 30,768 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-16 | BAKER FELIX | Director | Buy | 30,768 | $1.1M |
| 2026-09-16 | BAKER BROS. ADVISORS LP | Director | Buy | 30,768 | $1.1M |
| 2026-09-16 | BAKER BROS. ADVISORS LP | Director | Buy | 30,768 | $1.1M |
| 2026-09-16 | Baker Brothers Life Sciences LP | Director | Buy | 30,768 | $1.1M |
| 2026-09-16 | 667, L.P. | Director | Buy | 30,768 | $1.1M |
| 2026-09-16 | Baker Bros. Advisors (GP) LLC | Director | Buy | 30,768 | $1.1M |
| 2026-09-16 | BAKER JULIAN | Director | Buy | 30,768 | $1.1M |
| 2026-09-16 | BAKER FELIX | Director | Buy | 30,768 | $1.1M |
| 2026-09-16 | BAKER JULIAN | Director | Buy | 30,768 | $1.1M |
| 2026-09-16 | Baker Brothers Life Sciences LP | Director | Buy | 30,768 | $1.1M |
| 2026-09-16 | 667, L.P. | Director | Buy | 30,768 | $1.1M |
| 2026-09-16 | Baker Bros. Advisors (GP) LLC | Director | Buy | 30,768 | $1.1M |
| 2026-09-10 | Wang Xiaodong | Director | Sell | 2,841 | $983,433 |
| 2026-09-10 | Wang Xiaodong | Director | Sell | 1,517 | $526,993 |
| 2026-09-10 | Wang Xiaodong | Director | Sell | 1,721 | $598,930 |
| 2026-09-10 | Wang Xiaodong | Director | Buy | 31,027 | $1.1M |
| 2026-09-10 | Wang Xiaodong | Director | Sell | 7,492 | $2.6M |
| 2026-09-10 | Wang Xiaodong | Director | Sell | 10,688 | $3.7M |
| 2026-09-10 | Wang Xiaodong | Director | Sell | 1,181 | $407,897 |
| 2026-09-10 | Wang Xiaodong | Director | Sell | 6,278 | $2.2M |
| 2026-09-10 | Wang Xiaodong | Director | Sell | 6,569 | $2.3M |
| 2026-09-03 | Ball Titus B. | Principal Accounting Officer | Sell | 132 | $46,974 |
| 2026-08-27 | Wu Xiaobin | President and COO | Sell | 280 | $106,400 |
| 2026-08-13 | Lee Chan Henry | SVP, General Counsel | Buy | 1,058 | $225,693 |
| 2026-08-13 | Lee Chan Henry | SVP, General Counsel | Buy | 812 | $157,910 |
来源：SEC Form 4 申报文件 · 截至 2026-09-16